- Small and mid-market deals were the main drivers of record investment activity in H1, but we expect large deal activity to pick up in H2.
- The secondary market is on track for a record year as investors look to meet their liquidity needs either by selling LP stakes or, more commonly in the last year, exiting through GP-led transactions.
- In H1, we committed EUR 338m to investments, including EUR 111m invested in 9 secondary transactions and EUR 151m invested in 6 direct co-investments.
In the first half of 2021, private equity investment activity was at its highest level over a six month period since records began four decades ago. To some extent, this was driven by a large pipeline of deals which were delayed in 2020 due to the pandemic. However, it also reflects continued positive investor sentiment as recent private equity performance has shown remarkable resilience. Similar to 2020, the small end of the market has been the driving force of this investment surge. On the other side of the coin, exit activity is almost back to pre-COVID levels. However, distributions overall are continuing to lag capital calls. This mismatch is a key driver behind the continued growth in the secondary market, as some investors require alternative exit routes as a way to bridge the liquidity gap.
Small deal activity leads the charge
The global aggregate value of private equity deals closed during H1 2021 was EUR 452bn, 51% up on the first half of last year1. Activity was strong in all regions with North America (+58%) posting the highest increase, given that the fall in this region had been most dramatic in the first half of 2020.
Notably, investment activity in small and mid-market companies (defined as deals with an enterprise value of less than EUR 500m) accounted for most of the growth. The aggregate value of small and mid-market deals increased by 78% in the first half, compared to 25% for large deals. This was a phenomenon universal to all regions.
Since the onset of the pandemic, small and mid-market private equity firms have been quick off the mark and have taken advantage of opportunities in niche sectors which have shown greatest resilience. In 2021, at the large end of the market, there have already been some eye-catching headlines such as the acquisition of medical supply giant Medline for USD 34bn by Blackstone, Carlyle and Hellman & Friedman (the largest buyout since the GFC). However, while large firms have been busy working on deals since mid-last year, they are yet to close a significant number. This is because large deals typically take longer to carry out the due diligence, negotiate and structure than small deals, especially during a time when travel is restricted. Nevertheless, we would expect large deal activity to pick up in the latter part of this year.
Figure 1: Investment Activity by Deal Size (EUR bn)
Source: Pitchbook. Data as at July.2021
In the last 12 months, Unigestion Direct II has made 11 investments. Given the high number of deals we are seeing, we have been able to invest in high quality small and mid-market companies playing our key investment themes at attractive valuations. We have become adept at conducting rigorous due diligence on these companies through virtual management meetings, expert interviews and thorough desktop modelling and analysis.
In June 2021, we closed an investment in Stronger, a Danish womenswear brand in the niche Athleisure market. Driven by our Personal Well-being theme, the sector is growing at over 15% per year. With our investment partner, Polaris, the value creation plan is to continue its international expansion, upgrade the company’s supply chain and implement best-in-class ESG practices (such as the use of recycled materials and carbon emission reduction).
After a slump in 2020, exit activity is now back to pre-COVID levels. The global aggregate value of exits in H1 2021 was EUR 323bn, 74% up on the first half of last year and exactly in line with H1 20192. North America (+93%) saw the biggest increase but activity was also robust in Europe (+48%) and APAC (+40%).
Given the high number of deals we are seeing, we have been able to invest in high quality, small and mid-market companies playing our key investment themes at attractive valuations.
The IPO market was particularly red hot in the first half of the year. Across markets globally, H1 2021 saw the highest ever public market issuance volume, which includes IPOs and follow-on offerings, at USD 916bn3. In fact, June 2021 was the busiest single month for US IPOs since August 2000. The boost in volumes can be attributed to a number of factors, principally a high quality pipeline backlog (due to COVID) and positive IPO aftermarket performance. Across the private equity market, there have been a total of 456 IPOs, the highest number in more than a decade. However, this still only accounted for 18% of all exits by number, given that most PE exits are via trade or secondary sales.
Despite the resumption of exit activity, overall distributions back to investors are unlikely to match the elevated capital drawdowns they will be making given the heightened investment activity. Consequently, we estimate that investors in aggregate for 2021 will see negative cash flows from their private equity programmes for the third year running.
This explains why the secondary market continues to be extremely active and is on track for its biggest ever year. Desiring liquidity from more mature investments, many investors are either selling LP stakes or, more commonly in the last year, exiting through GP-led transactions.
In our latest secondary strategy, Unigestion Secondary V, we have been benefiting from this trend. In the last nine months, we have closed 11 GP-led transactions across the US, Europe and APAC. As a reminder, our secondaries strategy is to focus on small transactions of concentrated portfolios, often just 1 to 6 companies, with attractive valuations and where we have excellent visibility on the portfolio through a strong relationship with the GP.
Through tailored GP-led transactions, we can target high quality companies aligned with our investment themes and where there is substantial value creation potential through either organic growth or add-on acquisitions. This is demonstrated by our latest investment in Unigestion Secondary V, a single asset restructuring of ABC Design, led by Invision, a small and mid-market GP focused on the DACH region whom we have known for over 11 years. ABC Design is the leading brand for baby products such as strollers and car seats in the DACH region. The company showed impressive growth in 2020 (+26%) but still has further growth potential. For example, although ABC Design is present in more than 40 countries, over 80% of its revenues are generated in its home market, Germany.
In 2020, the pandemic made it very difficult for new private equity managers raising their first or second fund to catch the attention of investors. As widely reported, most investors focused on re-ups with their established GP relationships.
In the last nine months, we have closed 11 GP-led transactions across the US, Europe and APAC.
We are now seeing a pent-up supply of these emerging managers coming to the market with their new funds. Emerging managers have attracted the interest of investors for many years, becoming a dedicated investment strategy for many. The space has also been gaining momentum thanks to an increase in PE professionals desiring to set up new firms, a strong macro tailwind, and the preference of many investors to diversify their exposures away from the larger funds currently forming the core of their private equity exposure.
In the past, these emerging managers were typically formed by former investment bankers or the like. Today, it is more often spin-out teams of larger and well-established players, or family offices with proven track records and significant experience. These teams have a strong entrepreneurial drive and desire for greater control of the investment strategy, but also see an opportunity to focus on more specialist strategies and exploit new market niches.
We see a number of attractions in backing emerging managers:
- Access to specialist strategies: Emerging managers typically launch funds with specialist strategies consistent with their track record. They may be sector specialists with specific themes (e.g. Healthtech, Foodtech, Enterprise Software, etc.) or strategy specialists (e.g. Buy & Build, Growth, Complex Buyouts, etc.). This focus on specialist strategies with highly experienced teams can drive outstanding returns with downside protection.
- Ability to minimise the Total Expense Ratio (TER): Committing to first time funds, in particular for investors with the ability to cornerstone funds and support GPs with best practice coaching, allows for various special terms to be negotiated. These may include staggered carry schemes, short duration funds, cornerstone/first closer discounts, or fee-free co-investment rights. On a total cost basis, the final fee load can be significantly reduced relative to standard market terms.
- Priority access to co-investments: Emerging managers typically offer more co-investments than larger, established managers. Often, these can be negotiated up front, for example, by combining a commitment in a GP’s fund to a co-investment in the first one or more portfolio companies. There may also be an agreement on a target ratio of fund commitments to co-investments or simply a right of first refusal for any co-investment opportunities that may arise. As well as reducing the TER, a high ratio of co-investments can reduce the blind pool risk by allowing investors to diligence a deal, and ensure faster deployment of capital.
- Access to successor funds: Committing to promising emerging managers early on is the best way to ensure future allocations. The combination of strong returns and moderate fund sizes means that access to these rising stars will be severely restricted for LPs wanting to jump onto the bandwagon at a later stage. Some of the best known small and mid-market managers today became difficult to access for new investors by the time they were raising their second or third fund, given their early success.
Today, emerging managers are more often spin-out teams of larger and well-established players, or family offices with proven track records and significant experience.
At Unigestion, we have historically committed over EUR 1.4bn to first or second funds of emerging managers, representing c40% of all our primary commitments since 1996. Not only have such managers become some of our most enduring and rewarding GP relationships but they have historically driven significant dealflow for our direct and secondaries strategies. To date, eight of the 12 investments in Unigestion Direct II and eight of the 11 investments in Unigestion Secondary V came from investment partners who began as emerging manager relationships for us.
Unigestion Private Equity Activity
In the first half of 2021, the Unigestion private equity team committed EUR 338m to investments. We have closed five new primary funds of EUR 77m. In addition, we completed nine secondary transactions totalling EUR 111m, and closed six direct co-investments of EUR 151m in total.
In April, we committed to Cow Corner I on behalf of Emerging Manager Choice. Cow Corner is a buy & build specialist focusing on highly resilient and high-growth companies, providing typically B2B or B2C mission critical, non-discretionary professional services in the UK.
At the time of closing, the Fund had made four investments. More recently, Cow Corner invested in The Learning People, an online education player providing training for people willing to enter or reskill in order to work in the IT sector, which is hiring the most in the UK.
During the second quarter, Emeram I, a GP-led deal which we completed in 2019 for our secondary programmes, exited two companies. Emeram sold Matrix42 (www.matrix42.com) in April to the private equity firm Corten Capital Investment, resulting in a gross TVPI of 4.5x. Matrix42 is a global provider of innovative solutions for digital workspace management. Used by more than 5,000 customers worldwide, Matrix42 automates mission-critical IT and business support processes, license and cloud expense management, and related enterprise workflows. The exit generated proceeds of EUR 16.4m.
In June, Emeram exited Meona (www.meona.de) to the private equity firm Trill Impact, resulting in a gross TVPI of 2.7x and 31% gross IRR. Meona is a provider of clinical software, which is used by universities and hospitals to digitise their processes. The exit generated proceeds of EUR 4.9m.
In May, Unigestion Direct II closed a co-investment in LMG Holdings (www.lmgholdings.com), the leading provider of ignition interlock devices, which prevent a vehicle from starting if operators have an unacceptable amount of alcohol in their system. Our investment supported the acquisition of Scram Systems (www.scramsystems.com), an add-on for LMG Holdings.
LMG Holdings is a mission driven business providing offenders with a way to keep their jobs and remain integrated into society, and benefits from legislative and political tailwinds seeking to reduce the cost and rates of incarceration in the justice system. As such, the business delivers clear ESG benefits.
In May, Unigestion Direct II also closed a co-investment in Stronger (www.strongerlabel.com). Stronger is a Swedish direct-to-consumer Athleisure company with a broad portfolio of training/fitness/casual wear clothing for women, with tights and leggings being their core and bestselling products.
The company has a clear position in the market with a differentiated brand image centred around female empowerment, healthy lifestyles and leisure – not performance-oriented nor associated with a particular sport.
In the same month, we committed to Pollen Street IV, a fund focused on financial and business services in the UK and Europe. Pollen Street makes controlled investments in financial services businesses across lending, payments, technology, insurance and wealth management.
Downside protection is characterised by long-term customer relationships, a strong recurring revenue base and cash flows, and a technological platform with intellectual property rights.
In June, we completed a single asset restructuring in ABC Design (www.abc-design.de). ABC Design is a leading brand for baby products, such as strollers, car seats and accessories, in the DACH region.
The company is managed by Swiss-based Invision. Thanks to our strong relationship with the fund manager, we obtained exclusive access to the deal. ABC Design sees continuing growth driven by increasing birth numbers and increasing disposable income among parents.
Also in June, Priveq V, one of the Nordic funds in Euro Choice VI (EC VI), exited two companies generating gross proceeds of EUR 8.8m. One company is Omegapoint (www.omegapoint.se), a Swedish IT services firm specialising in secure digital transformation and cyber security with a market leading position in Sweden. The transaction resulted in a gross TVPI of 5.2x and 52% gross IRR. The other company is ILT Education (www.inlasningstjanst.se), a leading supplier of educational tools for schools and preschools, with a focus on digital audio and visual-assisted learning solutions. The transaction resulted in a gross TVPI of 5.6x and 49% gross IRR.
In the same month, Unigestion Direct II closed a co-investment in Nesperta (www.nesperta.com). Nesperta is the Polish market leader in the sector of innovative UV nail polish products, with its main brand Semilac accounting for more than 25% of market share in Poland.
The UV nail care segment is expected to outperform the traditional polish segment, thanks to increased durability and superior colour expression. The company’s key competencies are in product positioning, marketing and omni-channel distribution.
Unigestion Direct II also closed a co-lead investment in Deeper (www.deepersonar.com). Deeper is the global leader in the niche market of castable sonars for anglers with ca. 80% market share worldwide. Castable sonars are used by anglers in freshwater fishing to observe fish and monitor the features of the water basin.
Deeper’s brand is very well positioned versus competitors and its operating model is focused on product development, marketing and distribution, while manufacturing activities are outsourced to specialised electronics assemblers.
1,2Pitchbook, July 2021
3Goldman Sachs, July 2021.
Past performance is no guide to the future, the value of investments, and the income from them change frequently, may fall as well as rise, there is no guarantee that your initial investment will be returned. This document has been prepared for your information only and must not be distributed, published, reproduced or disclosed (in whole or in part) by recipients to any other person without the prior written consent of Unigestion. It is neither directed to, nor intended for distribution or use by, any person or entity who is a citizen or resident of, or domiciled or located in, any locality, state, country or jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation.
This is a promotional statement of our investment philosophy and services only in relation to the subject matter of this presentation. It constitutes neither investment advice nor recommendation. This document represents no offer, solicitation or suggestion of suitability to subscribe in either the investment vehicles to which it refers or to any securities or financial instruments described herein. Any such offer to sell or solicitation of an offer to purchase shall be made only by formal offering documents, which include, among others, a confidential offering memorandum, limited partnership agreement (if applicable), investment management agreement (if applicable), operating agreement (if applicable), and related subscription documents (if applicable). Such documentation contains additional information material to any decision to invest. Please contact your professional adviser/consultant before making an investment decision.
Where possible we aim to disclose the material risks pertinent to this document. The views expressed in this document do not purport to be a complete description of the securities, markets and developments referred to in it. Reference to specific securities should not be considered a recommendation to buy or sell. Unigestion maintains the right to delete or modify information without prior notice.
Investors shall conduct their own analysis of the risks (including any legal, regulatory, tax or other consequences) associated with an investment and should seek independent professional advice. Some of the investment strategies or financial instruments described or alluded to herein may be construed as high risk and not readily realisable investments, which may experience substantial and sudden losses including total loss of investment. These are not suitable for all types of investors. Unigestion has the ability in its sole discretion to change the strategies described herein.
To the extent that this report contains statements about the future, such statements are forward-looking and subject to a number of risks and uncertainties, including, but not limited to, the impact of competitive products, market acceptance risks and other risks. Actual results could differ materially from those in the forward-looking statements. As such, forward looking statements should not be relied upon for future returns. Targeted returns reflect subjective determinations by Unigestion based on a variety of factors, including, among others, internal modeling, investment strategy, prior performance of similar products (if any), volatility measures, risk tolerance and market conditions. Targeted returns are not intended to be actual performance and should not be relied upon as an indication of actual or future performance.
No separate verification has been made as to the accuracy or completeness of the information herein. Data and graphical information herein are for information only and may have been derived from third party sources. Unigestion takes reasonable steps to verify, but does not guarantee, the accuracy and completeness of information from third party sources. As a result, no representation or warranty, expressed or implied, is or will be made by Unigestion in this respect and no responsibility or liability is or will be accepted. All information provided here is subject to change without notice. It should only be considered current as of the date of publication without regard to the date on which you may access the information. Rates of exchange may cause the value of investments to go up or down. An investment with Unigestion, like all investments, contains risks, including total loss for the investor.
Unigestion Direct II (UDII) has been created as a SCS-SICAV-RAIF in Luxembourg and qualifies as an Alternative Investment Fund (AIF) within the meaning of the law dated 12 July 2013 on Alternative Investment Fund Managers implementing the Directive 2011/61/EU (AIFMD). As a result, units of this vehicle may be offered only to professional investors and may not be distributed on a public basis in or from any country where such distribution would be prohibited by law. This document contains a preliminary summary of the purpose and principal business terms of an investment in UDII. This summary does not purport to be complete and is qualified in its entirety by reference to the more detailed discussion to take place with the AIF. UDII has the ability in its sole discretion to change the strategies described herein. Before making a decision to invest in UDII, you are advised to consult with your tax, legal and financial advisors.
UnigestionFLEX has been created as a SCS-SICAV-RAIF in Luxembourg and will qualify as an Alternative Investment Fund (AIF) within the meaning of the law dated 12 July 2013 on Alternative Investment Fund Managers implementing the Directive 2011/61/EU (AIFMD). As a result, units of this vehicle may be offered only to professional investors and may not be distributed on a public basis in or from any country where such distribution would be prohibited by law. This document contains a preliminary summary of the purpose and principal business terms of an investment in UnigestionFLEX. This summary does not purport to be complete and is qualified in its entirety by reference to the more detailed discussion to take place with the AIF. UnigestionFLEX will have the ability in its sole discretion to change the strategies described herein. Before making a decision to invest in UnigestionFLEX, you are advised to consult with your tax, legal and financial advisors.
Unigestion Secondary V (USec V) has been created as a SCS-SICAV-RAIF in Luxembourg and will qualify as an Alternative Investment Fund (AIF) within the meaning of the law dated 12 July 2013 on Alternative Investment Fund Managers implementing the Directive 2011/61/EU (AIFMD). As a result, units of this vehicle may be offered only to professional investors and may not be distributed on a public basis in or from any country where such distribution would be prohibited by law. This document contains a preliminary summary of the purpose and principal business terms of an investment in Unigestion Secondary V. This summary does not purport to be complete and is qualified in its entirety by reference to the more detailed discussion to take place with the AIF. Unigestion Secondary V will have the ability in its sole discretion to change the strategies described herein. Before making a decision to invest in Unigestion Secondary V, you are advised to consult with your tax, legal and financial advisors.
Euro Choice Secondary II L.P. has been created as a Scottish Limited Partnership. As a result, units of this vehicle may not be offered or distributed on a public basis in or from any country where such distribution would be prohibited by law. This document contains a preliminary summary of the purpose and principal business terms of an investment with Unigestion. This summary does not purport to be complete and is qualified in its entirety by reference to the more detailed discussion to take place with Unigestion. Unigestion has the ability in its sole discretion to change the strategies described herein. Before making a decision to invest with Unigestion you are advised to consult with your tax, legal and financial advisers.
Additional Information for US Investors
The performance figures are based on estimated fees and expenses as well as on the underlying strategy’s estimated performances given by fund managers, administrators, custodians and third party sources at a given date. Where performance is reflected gross of fees, potential investors should be aware that the inclusion of fees, costs and charges will reduce the overall value of performance. Unless otherwise stated, the performance data source are Unigestion, Bloomberg and Compustat.
This information is provided to you solely to give you background information relating to Unigestion, certain strategies it implements and currently offers. Before making an investment decision with respect to the strategy discussed herein, potential investors are advised to consult with their tax, legal, ERISA and financial advisors. Note that not all strategies may be available or suitable for investment by U.S. investors.
This document may contain forward-looking statements, including observations about markets and industry and regulatory trends as of the original date of this document. Forward-looking statements may be identified by, among other things, the use of words such as “expects,” “anticipates,” “believes,” or “estimates,” or the negatives of these terms, and similar expressions. Forward-looking statements reflect Unigestion’s views as of such date with respect to possible future events. Actual results could differ materially from those in the forward-looking statements as a result of factors beyond a strategy’s or Unigestion’s control. Readers are cautioned not to place undue reliance on such statements. No party has an obligation to update any of the forward-looking statements in this document
Return targets or objectives, if any, are used for measurement or comparison purposes and only as a guideline for prospective investors to evaluate a particular investment program’s investment strategies and accompanying information. Performance may fluctuate, especially over short periods. Targeted returns should be evaluated over the time period indicated and not over shorter periods.
The past performance of Unigestion, its principals, shareholders, or employees is not indicative of future returns.
Except where otherwise specifically noted, the information contained herein, including performance data and assets under management, relates to the entire affiliated group of Unigestion entities over time including that of Unigestion UK. Such information is intended to provide the reader with background regarding the services, investment strategies and personnel of the Unigestion entities. No guarantee is made that all or any of the individuals involved in generating the performance on behalf the other Unigestion entities will be involved in managing any client account on behalf of Unigestion U.K. More specific information regarding Unigestion UK is set forth herein where indicated and is available on request.
There is no guarantee that Unigestion will be successful in achieving any investment objectives. An investment strategy contains risks, including the risk of complete loss.
The risk management practices and methods described herein are for illustrative purposes only and are subject to modification.
Legal Entities Disseminating This Document
This material is disseminated in the United Kingdom by Unigestion (UK) Ltd., which is authorized and regulated by the Financial Conduct Authority (“FCA”). This information is intended only for professional clients and eligible counterparties, as defined in MiFID directive and has therefore not been adapted to retail clients.
This material is disseminated in the U.S. by Unigestion (UK) Ltd., which is registered as an investment adviser with the U.S. Securities and Exchange Commission (“SEC”). This information is intended only for institutional clients and qualified purchasers as defined by the SEC and has therefore not been adapted to retail clients.
This material is disseminated in the European Union by Unigestion Asset Management (France) SA which is authorized and regulated by the French “Autorité des Marchés Financiers” (“AMF”).
This information is intended only for professional clients and eligible counterparties, as defined in the MiFID directive and has therefore not been adapted to retail clients.
This material is disseminated in Canada by Unigestion Asset Management (Canada) Inc. which is registered as a portfolio manager and/or exempt market dealer in nine provinces across Canada and also as an investment fund manager in Ontario, Quebec and Newfoundland & Labrador. Its principal regulator is the Ontario Securities Commission (“OSC”). This material may also be distributed by Unigestion SA which has an international advisor exemption in Quebec, Saskatchewan and Ontario. Unigestion SA’s assets are situated outside of Canada and, as such, there may be difficulty enforcing legal rights against it.
This material is disseminated in Switzerland by Unigestion SA which is authorized and regulated by the Swiss Financial Market Supervisory Authority (“FINMA”).
Document issued August 2021.